• Skip to primary navigation
  • Skip to main content

Yamo Pharmaceuticals

Cutting Edge Pharmaceutial Technologies

  • About Us
    • Company Overview
    • Our Team
    • Scientific Advisory Board
  • Our Technology
    • Yamo’s Treatment for Autism
    • About Autism
  • Information for Patients and Caregivers
    • Future Clinical Studies
    • Compassionate Use Policy
  • News & Publications
  • Contact Us
    • General Inquiries
    • Participation in Future Clinical Studies

Uyen Nguyen

Vice President of Clinical Research Operations

  • Ms. Nguyen has 17+ years of experience in R&D and clinical research operations in the pharmaceutical industry
  • Ms. Nguyen previously held key roles in clinical operations for Prometheus, Spectrum Pharmaceuticals and Pfizer, as well as in R&D project management at Valeant Pharmaceuticals
  • During her tenure at Avanir Pharmaceuticals, from 2012 to 2014, Ms. Nguyen managed a critical Phase 2 study with positive outcomes. Once Avanir Pharmaceuticals was acquired by Otsuka Holdings in 2015, Ms. Nguyen was placed in the lead role as director for their flagship clinical program consisting of 4 large U.S. and global Phase 3 trials
  • Ms. Nguyen holds a BS in Chemistry from Allegheny College
  • Copyright © 2025 Yamo Pharmaceuticals
  • Terms and Conditions
  • Privacy Policy